Any detectable admission cardiac troponin I level is associated with increased risk of early death following COPD exacerbations

P. R. Vamadevan, A. W. Hitchings, T. S. Grewal, D. Ahnood, E. H. Baker (London, United Kingdom)

Source: Annual Congress 2011 - Diagnosis and predictors of COPD exacerbation
Session: Diagnosis and predictors of COPD exacerbation
Session type: Oral Presentation
Number: 401
Disease area: Airway diseases

Congress or journal article abstractSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
P. R. Vamadevan, A. W. Hitchings, T. S. Grewal, D. Ahnood, E. H. Baker (London, United Kingdom). Any detectable admission cardiac troponin I level is associated with increased risk of early death following COPD exacerbations. Eur Respir J 2011; 38: Suppl. 55, 401

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Relationships between elevated cardiac troponin levels in COPD exacerbations and subsequent cardiac investigation and management
Source: Annual Congress 2011 - COPD exacerbation
Year: 2011

Acute exacerbation of COPD is associated with three-fold elevation of cardiac troponin T
Source: Annual Congress 2012 - Acute exacerbation in COPD
Year: 2012


Elevated cardiac troponin I levels in acute pulmonary embolism predict increased long-term mortality
Source: Eur Respir J 2005; 26: Suppl. 49, 271s
Year: 2005

Assessment of premature death risk after recovery from COPD exacerbation
Source: Annual Congress 2010 - COPD: treatment and monitoring
Year: 2010


Prognostic value of high troponin levels in acute COPD attack patients with respiratory insufficiency
Source: Annual Congress 2008 - Biomarkers and disease assessment in COPD
Year: 2008


BNP is a predictor of mortality following COPD exacerbations
Source: Annual Congress 2011 - Diagnosis and predictors of COPD exacerbation
Year: 2011

Elevated cardiac troponin predicts 11-year mortality in COPD
Source: Virtual Congress 2020 – Comorbidities/multimorbidites and mortality in patients with chronic lung diseases
Year: 2020


High-sensitivity cardiac troponin T is associated with increased mortality in patients with stable chronic obstructive pulmonary disease
Source: International Congress 2015 – Risk factors and co-morbidities in asthma and COPD
Year: 2015


Is a cardiopulmonary exercise test (CPET) associated with an increase in high sensitivity cardiac troponin T (hs-cTnT) levels in patients with COPD?
Source: International Congress 2017 – Lung function practice in daily life
Year: 2017


Cardiac troponin I elevation in the exacerbations of severe COPD
Source: Annual Congress 2008 - Biomarkers and disease assessment in COPD
Year: 2008


Evaluation of serum troponin level in exacerbation of COPD
Source: Eur Respir J 2005; 26: Suppl. 49, 299s
Year: 2005

The significance of the adherence to the discharge criteria in patients with acute exacerbation of COPD on early readmission
Source: International Congress 2017 – COPD management
Year: 2017


Increasing risk of exacerbation and mortality associated with increasing frequency and severity of exacerbations in COPD patients: EXACOS-UK
Source: Virtual Congress 2021 – Prediction of exacerbations in patients with COPD
Year: 2021


Elevated blood eosinophils on admission for a severe exacerbation of COPD is not a predictor for survival
Source: International Congress 2017 – COPD: from screening to risk factors of lung cancer
Year: 2017

Serum hyaluronidase-1 is increased in COPD exacerbations and is associated with COPD severity and outcomes
Source: International Congress 2018 – Disease exacerbations from a molecular point of view
Year: 2018



CAB score predicts short-term mortality at hospital admission for acute exacerbations of COPD
Source: International Congress 2017 – COPD management: new findings from large studies
Year: 2017



Circulating desmosine levels do not predict emphysema progression but are associated with cardiovascular risk and mortality in COPD
Source: Eur Respir J 2016; 47:1365-1373
Year: 2016



In hospitalized COPD exacerbation (COPDE) patients a 30-day readmission is associated with a progressive increased risk of mortality
Source: International Congress 2015 – COPD: interesting notes
Year: 2015

Glitazones are associated with reduced risk of COPD exacerbations and mortality among patients with diabetes
Source: Annual Congress 2011 - COPD: burden of disease, imaging and management
Year: 2011

Increased prevalence of elevated high-sensitivity cardiac troponin T among patients with stable chronic obstructive pulmonary disease
Source: Annual Congress 2011 - Respiratory epidemiology: comorbidity
Year: 2011